To sum up, CTNNB1 mutation tended toward higher TMB, higher ICI score, and lower immune cell infiltration, which better predicted immunotherapy response and may be a prognostic predictor in HCC patients. Here, CTNNB1 is linked to hepatocellular carcinoma.